𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose intravenous IgG treatment and acute renal failure

✍ Scribed by B. Veber; I. Mohammedi; B. Gachot; J. P. Bédos; M. Wolff

Publisher
Springer
Year
1995
Tongue
English
Weight
255 KB
Volume
21
Category
Article
ISSN
1432-1238

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute renal failure in high dose carbopl
Acute renal failure in high dose carboplatin chemotherapy
✍ Frenkel, Joost ;Kool, Gea ;De Kraker, Jan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

## Abstract Carboplatin has been reported to cause acute renal failure when administered in high doses to adult patients. We report a 4 1/2‐year‐old girl who was treated with high‐dose carboplatin for metastatic parameningeal embryonal rhabdomyosarcoma. Acute renal failure developed followed by a s

Intravenous gammaglobulin-associated acu
Intravenous gammaglobulin-associated acute renal failure
✍ N. Gupta; I. Ahmed; S. Nissel-Horowitz; D. Patel; B. Mehrotra 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 14 KB 👁 2 views

Intravenous gammaglobulins are used for the treatment of various auto-immune hematological disorders. Renal failure is a relatively rare, but an increasingly recognized side effect of gammaglobulin therapy. Although the renal failure is usually reversible, renal replacement therapy is required occas

Acute renal failure associated with intr
Acute renal failure associated with intravenous immunoglobulins
✍ Valérie Gras; Michel Andréjak; Guillaume Decocq 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Intravenous immunoglobulins (IVIG) are increasingly used in various clinical situations for which they have been considered to be safe and eective. However, since 1987, some cases of renal toxicity have been reported. Forty-nine cases of acute renal failure have been noti®ed to the French Regional

High dose intravenous immunoglobulin tre
High dose intravenous immunoglobulin treatment: Mechanisms of action
✍ Peter Boros; Gabriel Gondolesi; Jonathan S. Bromberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Intravenous immunoglobulin (IVIg) treatment was introduced as replacement therapy for patients with antibody deficiencies, but evidence suggests that a wide range of immune-mediated conditions could benefit from IVIg. The immunoglobulins are precipitated from human plasma by fractionation methods. I